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Abstract: The efficacy of pregabalin in acute postsurgical pain has
been demonstrated in numerous studies; however, the analgesic efficacy
and adverse effects of using pregabalin in various surgical procedures
remain uncertain. We aim to assess the postsurgical analgesic efficacy
and adverse events after pregabalin administration under different
surgical categories using a systematic review and meta-analysis of
randomized controlled trials.
A search of the literature was performed between August 2014 to
April 2015, using PubMed, Ovid via EMBASE, Google Scholar, and
ClinicalTrials.gov with no limitation on publication year or language.
Studies considered for inclusion were randomized controlled trials,
reporting on relevant outcomes (2-, 24-hour pain scores, or 24 hour
morphine-equivalent consumption) with treatment with perioperative
pregabalin.
Seventy-four studies were included. Pregabalin reduced pain scores
at 2 hours in all categories: cardiothoracic (Hedge’s g and 95%CI,
0.442 [0.752 to 0.132], P¼ 0.005), ENT (Hedge g and 95%CI,
0.684 [1.051 to 0.316], P< 0.0001), gynecologic (Hedge g,
95%CI, 0.792 [1.235 to 0.350], P< 0.0001), laparoscopic chole-
cystectomy (Hedge g, 95%CI, –0.600 [–0.989 to –0.210], P¼ 0.003),
orthopedic (Hedge g, 95%CI, 0.507 [0.812 to 0.202], P¼ 0.001),
spine (Hedge g, 95%CI, 0.972 [1.537 to 0.407], P¼ 0.001), and
miscellaneous procedures (Hedge g, 95%CI, 1.976 [2.654 to
1.297], P< 0.0001). Pregabalin reduced 24-hour morphine consump-
tion in gynecologic (Hedge g, 95%CI, 1.085 [1.582 to 0.441],
P¼ 0.001), laparoscopic cholecystectomy (Hedge g, 95%CI, –0.886
[–1.652 to –0.120], P¼ 0.023), orthopedic (Hedge g, 95%CI, 0.720
[1.118 to 0.323], P< 0.0001), spine (Hedge g, 95%CI, 1.016
[1.732 to 0.300], P¼ 0.005), and miscellaneous procedures (HedgeA, FCAI, FANZCA d
KCA, FHKAM, Dip, Pain, Mgt
nausea and vomiting was only significant after pregabalin in miscella-
neous procedures.
Analgesic effects and incidence of adverse effects of using prega-
balin are not equal in different surgical categories.
(Medicine 94(46):e1944)
Abbreviations: CI = confidence interval, ENT = ear, nose and
throat, NRS = numeric rating scale, OR = odds ratio, PCA =
patient-controlled analgesia, PONV = postoperative nausea and
vomiting, RCT = randomized controlled trial, SD = standard
deviation, VAS = visual analogue scale.
INTRODUCTION
P regabalin is a structural analogue of gamma-aminobutyricacid that acts as a potent ligand for alpha 2-delta subunits of
the voltage-gated calcium channels in the nervous system. Such
action results in a reduction in the depolarization-induced influx
of calcium, hence a reduction in the release of excitatory
neurotransmitters including glutamate, noradrenaline, dopa-
mine, and serotonin.1 Compared with gabapentin, pregabalin
is more potent, is associated with fewer adverse effects, and has
a more predictable and linear pharmacokinetic profile.1,2 Its
absorption is extensive, rapid, and proportional to dose.1,2
Pregabalin is an attractive adjuvant for perioperative analgesia
in this regard as it can be taken on an empty stomach, does
not lead to gastrointestinal bleeding, and is generally well-
tolerated.3
A multimodal analgesic technique is now often employed
in acute postsurgical pain management in an attempt to improve
analgesic efficacy and decrease requirement for opioids that are
associated with undesirable adverse effects.4 Uses of pregabalin
therefore range from treatment of neuropathic pain to being an
adjunct in the multimodal management of postsurgical pain.4
The efficacy of pregabalin in treating acute postsurgical
pain has been demonstrated in numerous studies. A recent meta-
analysis has suggested that pregabalin, at all doses and admin-
istration regimens, has opioid-sparing effects and reduces pain
scores in the postsurgical setting,5 at the expense of increased
sedation and visual disturbances; however, the efficacy of
pregabalin in providing such in various surgical categories
remains uncertain, and it is not known whether the risk : benefit
ratio is greater for certain surgical categories. Therefore, the aim
of this meta-analysis was to evaluate the analgesic efficacy of
pregabalin in reducing postsurgical pain in terms of 2- and 24-
hour postsurgical visual analogue scale (VAS) pain scores andmorphine-equivalent consumption, in




This review was performed according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
guidelines for reporting meta-analyses, http://links.lww.com/
MD/A495.6 Approval by ethics committee or written consent
were not required for the extraction of data on studies already
conducted for the purposes of this meta-analysis. Before com-
mencing this meta-analysis, all authors agreed on the inclusion
and exclusion criteria, which were articles with at least the
abstract published in English, and gave data on at least 1 of the
primary outcomes. This protocol was not published.
Eligibility Criteria
Studies considered for inclusion in the meta-analysis were
randomized, double-blinded, controlled trials (RCTs) that
investigated a minimum of 10 subjects in each group6 and
reported on relevant pain outcomes with intervention or treat-
ment with perioperative pregabalin. These studies had to present
data for at least 1 of our prespecified outcome variables, which
were 2- or 24-hour postsurgical pain or 24-hour morphine-
equivalent consumption.
Systematic Search
A comprehensive search for literature for pregabalin was
performed between August 2014 to April 2015, using PubMed,
Ovid via EMBASE, Google Scholar, and ClinicalTrials.gov
with no limitation on the year of publication or language.
Attempts were made at accessing www.clinicalstudyresults.org
to identify potentially relevant studies that have not been
published in medical journals, but the website is no longer in
use. The keywords used in the search included ‘‘pregabalin,’’
‘‘lyrica,’’ ‘‘analgesia,’’ ‘‘acute pain,’’ ‘‘post-surgical pain,’’ and
‘‘post-operative pain.’’ Identified references were screened
using title, abstract, and keywords. Searches of the reference
lists of identified studies were also made.
Study Selection and Data Collection
Two primary investigators (D.M.H.L. and S.W.C.)
screened the titles independently and removed the studies that
did not meet the specified screening criteria. Abstracts, litera-
ture reviews, and meta-analyses were excluded. Potentially
eligible trials were analyzed in detail on the basis of the full
text and disagreements were discussed between D.M.H.L. and
S.W.C. Data extraction was performed by the 2 reviewers
(D.M.H.L. and S.W.C.) independently and included data on
the patient (number of subjects, type of surgery, and type of
anesthesia), data on the intervention and control (dose and
frequency of pregabalin administered), and data on the out-
comes (pain intensity, given as acute pain scores at rest, total
opioid-equivalent consumption, and adverse effects including
nausea, vomiting, sedation, and visual disturbance). Assessing
each study for surgical category was performed by D.M.H.L.
and C.-W.C.
Data Extraction
The pain intensity measured by either VAS or numeric
rating scale (NRS) was extracted as pain scores. These scales
have been shown to correlate well.7 The cumulative opioid
Lam et alconsumption at the closest time to 24 hours postsurgery was
extracted and converted to an equianalgesic dose of parenteral
morphine in mg, based on the following scale: 15 : 1 for
2 | www.md-journal.comhydromorphone, 1.3 : 1 for oxycodone, 1 : 100 for fentanyl,
20 : 1 for codeine, 10 : 1 for tramadol, 10 : 1 for pethidine,
4 : 1 for hydrocodone, 1 : 100 for remifentanil, 1 : 1 for piritra-
mide, and 1 : 1 for nalbuphine.8–11 If results were presented as
the number of doses given, data were extracted from the
methods section to ascertain the dosage and then converted
to equianalgesic dose of parenteral morphine in mg for inclusion
in the meta-analysis. Data regarding postsurgical analgesic
consumption were not included from studies that did not utilize
opioids during the postsurgical period12–14 or if data were
presented as the number of patients who required rescue
analgesics, although pain scores and other information from
these studies were included in the analysis whenever given.
The primary outcomes of this present study were pain
scores at rest at 2 and 24 hours postsurgery, and morphine-
equivalent consumption in the first 24 hours postsurgery. Sec-
ondary outcomes were sedation at first assessment and adverse
effects. Pain scores at 2 hours postsurgery were selected as the
first time point for analysis because pain prior to that time point
might be reduced by the effects of analgesics administered
during anesthesia. Where pain scores were not available at 2
hours postsurgery, the closest time point was used. Pain scores
and opioid consumption at 24 hours postsurgery were chosen in
this study as most trials assessed here ceased data collection
after 24 hours. Where data were presented graphically, the
originals were obtained from the authors or extracted from
graphs if no response was obtained from the authors. Twenty-
eight corresponding authors were emailed for further details
regarding data in the published studies. Seventeen of the
emailed authors replied with further data not available in the
published articles.
Studies were classified according to surgical categories,
these were gynecologic, orthopedic (not including spine
surgery), spine, ear, nose and throat (ENT), cardiothoracic
surgery, and laparoscopic cholecystectomy. Where studies
reported cumulative data on several different surgical categories
or if the authors were only able to find 1 or 2 studies of that
surgical category (eg, eye surgeries and breast surgeries), these
were included in a miscellaneous, or >1 surgical category,
group.
Assessment of Risk of Bias
The quality of the studies was assessed by 2 investigators
(D.M.H.L. and S.W.C.) independently, using the Cochrane
Collaboration’s tool for assessing risk of bias.15
Statistical Analysis
Meta-analysis was used to assess the pooled effects of
pregabalin 2 hours and 24 hours postsurgery. If the study
included different doses of pregabalin, the higher dosage was
used in this analysis. Data were analyzed using Comprehensive
Meta-Analysis software (version 2.2.064, Englewood, NJ).
Meta-regression was not performed in this review as a minimum
number of 10 studies per subgroup is required.16
VAS pain scores or NRS pain scores were extracted from
each study. Mean and standard deviation (SD) values were used
when available, but when median and range data were pre-
sented, the mean was estimated using the median value, or the
median value itself was used if the sample size exceeded 25
subjects in each group.17 In addition to the various different
Medicine  Volume 94, Number 46, November 2015scoring methods used to assess pain, another major consider-
ation was the heterogeneity of the studies, which included
different types of patients, different pregabalin regimens in
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
terms of time, dose and frequency, and method of adminis-
tration. To take into consideration the heterogeneity of the
studies, Hedge g standardized mean difference, which is the
difference between the 2 means divided by the pooled SD, with
a correction for small sample bias, using a random-effects
model was computated and reported as the effect size between
the pregabalin and the control groups. Hedge g was chosen as
most of the studies investigated in this meta-analysis were small
(<40 subjects per group). Hedge g is also an index of treatment
efficacy independent of the scoring system used to measure
efficacy, which is particularly useful in the present study as VAS
0–10, VAS 0–100 and NRS have all been used as pain
scoring systems.
With regard to the analysis of adverse effects of pregabalin,
in studies that have categorized patients according to a score
(eg, sedation score) and if continuous data were available, this
was inputted as means (SD). For studies that have categorized
patients according to none, slight, moderate, or severe sedation,
all patients, except those who had been classified as ‘‘none’’ by
the investigators were regarded as being sedated for the pur-
poses of this present meta-analysis, and these data were inputted
using dichotomous data handling techniques. A Forest plot was
generated for each endpoint and Hedge g with 95% confidence
intervals (CIs) were reported. Effects on dichotomous outcomes
such as visual disturbances, nausea, vomiting, and postsurgical
nausea and vomiting were reported using odds ratio (OR) with a
random-effects model. Publication bias was assessed using
Funnel plots (Comphrensive Meta-Analysis).18 Sensitivity
analysis was assessed using the 1 study removed technique.
For all tests, statistical significance was defined as a 2-tailed P
value of< 0.05.
RESULTS
Our primary search strategy identified 1700 publications.
Seventy-four studies were included in this meta-analysis
(Supplementary Figure 1, http://links.lww.com/MD/A495).
Results here were presented as all included studies and then
according to the surgical category.
Risk of Bias
The results of the risk of bias assessment are summarized
in Supplementary Table 1, http://links.lww.com/MD/A495.
Study Protocols
The study protocols of the included trials varied signifi-
cantly and led to considerable heterogeneity.
It is important to note that the primary outcomes as defined
in this meta-analysis were not necessarily the primary outcomes
of the published trials, and therefore those trials might not be
powered to detect significant differences for the variables
included in this meta-analysis. The primary outcomes of the
trials are given in Tables 1–7.
Effect of Pregabalin on Primary Outcomes in all
Surgical Categories
Two-Hour VAS pain scores
A total of 60 studies with a total of 2019 patients taking
pregabalin and 2019 patients on the control treatment that
reported pains scores at or around 2 hours postsurgery were
Medicine  Volume 94, Number 46, November 2015included. Overall, pregabalin reduced VAS pain scores at 2
hours postsurgery (Hedge g and 95%CI, 0.970 [1.197 to
0.743], z score 8.389, P< 0.0001), Figure 1.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.Twenty-Four Hour VAS Pain Scores
A total of 57 studies with a total of 2033 patients taking
pregabalin and 2033 patients on the control treatment that
reported pains scores at 24 hours postsurgery were included.
Overall, pregabalin reduced pain scores at 24 hours postsurgery
(Hedge g and 95%CI, 0.442 [0.665 to 0.220], z score
3.894, P< 0.0001), Figure 2.
Subgroup Analysis According to Dosing Regimen
Fifty-five studies that provided information on 24-hour
pain scores were categorized according to whether a single dose
(prior to surgery) or multiple doses (starting from the night, or
days prior to surgery) were administered. There was no differ-
ence seen in 24-hour pain scores in these 2 subgroups. Prega-
balin reduced pain scores at 24 hours postsurgery regardless of
whether a single dose (Hedge g and 95%CI, 0.566 [0.914 to
0.218], z score 3.191, P¼ 0.001), or multiple doses were
administered (Hedge g and 95%CI, 0.322 [0.571 to
0.073], z score 2.536, P¼ 0.011).
Twenty-Four Hour Morphine-Equivalent
Consumption
Forty-six studies with a total of 1610 patients taking
pregabalin and 1636 patients on the control treatment that
reported morphine-equivalent consumption at 24 hours post-
surgery were included. Overall, pregabalin reduced morphine-
equivalent consumption at 24 hours postsurgery (Hedge g and
95%CI, 0.932 [1.212 to 0.652], z score 6.519,
P< 0.0001), Figure 3.
Effect of Pregabalin on Primary Outcomes in
Different Surgical Categories
Cardiothoracic Procedures
There were 4 studies19–22 with a total of 107 patients
taking pregabalin and 110 patients on the control treatment in
this group. Pregabalin reduced the pain score at rest 2 hours
postsurgery (P¼ 0.005). No significant difference was seen in
pain score at rest at 24 hours postsurgery (P¼ 0.537) or
morphine-equivalent consumption (P¼ 0.239), Figure 4
(Table 8).
ENT Procedures
There were 6 studies12–14,23–25 with a total of 265 patients
taking pregabalin and 266 patients on the control treatment in
this group. Pregabalin reduced the pain score at rest 2 hours
postsurgery (P< 0.0001) and pain score at rest at 24 hours
postsurgery (P¼ 0.004). No statistically significant reduction
in morphine-equivalent consumption was seen (P¼ 0.568),
Figure 5.
Gynecologic Procedures
There were 17 studies26–42 with a total of 980 patients
taking pregabalin and 730 patients on the control treatment in
this group. Pregabalin reduced the pain score at rest 2 hours
postsurgery (P< 0.0001), pain score at rest at 24 hours post-
surgery (P¼ 0.001), and the morphine-equivalent consumption
(P¼ 0.001), Figure 6A.
Due to the heterogeneity within the gynecologic group, a
Meta-Analysis: Pregabalin in Acute Postoperative Painsubanalysis was performed on open hysterectomy studies
only.27–33,36,37,41,42 There were 11 studies with a total of 468
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Lam et al Medicine  Volume 94, Number 46, November 2015treatment in this group. Pregabalin reduced the pain score at rest
FIGURE 1. Forest plot for 2-hour pain scores.2 hours postsurgery (P¼ 0.004), pain score at rest at 24 hours
postsurgery (P¼ 0.003), and the morphine-equivalent con-
sumption (P¼ 0.002), Figure 6B.
Laparoscopic Cholecystectomy Procedures
There were 6 studies43–48 with a total of 273 patients
taking pregabalin and 225 patients on the control treatment in
this group. Pregabalin reduced the pain score at rest 2 hours
postsurgery (P¼ 0.003), pain score at rest at 24 hours post-
surgery (P¼ 0.036), and the morphine-equivalent consumption
(P¼ 0.023), Figure 7.
14 | www.md-journal.comOrthopedic Procedures
There were 12 studies49–60 with a total of 430 patients
taking pregabalin and 642 patients on the control treatment in
this group. Pregabalin reduced the pain score at rest 2 hours
postsurgery (P¼ 0.001), pain score at rest at 24 hours post-
surgery (P¼ 0.013), and the morphine-equivalent consumption
(P< 0.0001), Figure 8.
Spine Procedures
There were nine studies61–65,67–69,88 with a total of 291
patients taking pregabalin and 332 patients on the control
treatment in this group. Pregabalin reduced the pain score at
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
Medicine  Volume 94, Number 46, November 2015 Meta-Analysis: Pregabalin in Acute Postoperative Painrest 2 hours postsurgery (P¼ 0.001) and the morphine-equiv-
alent consumption (P¼ 0.005). No significant difference was
seen in pain score at rest at 24 hours postsurgery (P¼ 0.373),
Figure 9.
Miscellaneous Procedures
There were 20 studies41,66,70–87 with a total of 1165
patients taking pregabalin and 884 patients on the control
FIGURE 2. Forest plot for 24-hour pain scores.treatment in this group. Pregabalin reduced the pain score at
rest 2 hours postsurgery (P< 0.0001) and the morphine-equiv-
alent consumption (P¼ 0.006). No significant difference was
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.seen in pain score at rest at 24 hours postsurgery (P¼ 0.422),
Figure 10.
Common Adverse Effects of Pregabalin
Sedation Effects of Pregabalin
Thirty studies had included data on the sedative effects of
pregabalin,13,14,21,22,25,29,30,32,37,39,43,50–52,55–57,59,60,62,65–69,77,
79,82,85,87,88 with a total of 1147 patients taking pregabalin and
1170 patients on the control treatment. Subgroup analysis was
performed on studies according to the surgical categories
www.md-journal.com | 15
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Lam et al Medicine  Volume 94, Number 46, November 2015(number of studies) under cardiothoracic surgery (2), ENT
surgery (3), gynecologic surgery (4), laparoscopic cholecys-
tectomy (2), orthopedic surgery (7), spine surgery (6), and
miscellaneous surgery (6). Data from George et al30 could
not be included in the analysis as there was no difference in
sedation between the treatment and control group. With the
exception of ENT surgery, laparoscopic cholecystectomy and
gynecologic surgery, pregabalin was associated with sedation in
all other surgical categories (overall OR and 95% CI, 2.144
[1.640–2.803], z score 5.574, P< 0.0001), Table 8.
Visual Disturbances
Fifteen studies had included data on incidence of visual
disturbance (including blurred vision) after pregabalin admin-
istration,24,34,35,39,46,48,51,62,64,68,77,79,80,85,88 with a total of 491
patients taking pregabalin and 498 patients on control treatment.
There were not enough studies under different surgical
categories for subgroup analyses to be performed. Overall,
FIGURE 3. Forest plot for 24-hour morphine-equivalent consumppregabalin was found to be associated with an increased inci-
dence of visual disturbances (OR and 95%CI, 6.215 [3.317–
11.646], z score 5.702, P< 0.0001).
16 | www.md-journal.comNausea
Thirty-one studies had included data on nausea prevalence
after pregabalin administration,13,21,24,26,28,30,33,37,44,46,47,50–52,
54,56,57,59,60,63–65,67,68,70,71,77,85,86,88 with a total of 1067 patients
taking pregabalin and 1038 patients on the control treatment. It
was found that there was no difference in nausea incidence in
cardiothoracic surgery, ENT surgery, gynecologic surgery,
laparoscopic cholecystectomy, and spine surgery between preg-
abalin and control treatment groups. Pregabalin administration
was associated with reduced incidence of nausea in miscella-
neous surgery (OR and 95% CI, 0.138 [0.073–0.262], z score
6.085, P< 0.0001) and orthopedic surgery (OR and 95% CI,
0.586 [0.377–0.911], z score 2.373, P< 0.018). Overall
results showed that pregabalin reduced postsurgical nausea
(OR and 95% CI, 0.478 [0.365–0.626], z score 5.364,
P< 0.0001).
Vomiting
.A total of 22 studies provided information on vomiting
incidence after pregabalin administration,13,21,23,25,44,46,47,50–52,
54,56,59,60,63,65,67,68,70,71,77,85 with 826 patients treated with
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
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Medicine  Volume 94, Number 46, November 2015 Meta-Analysis: Pregabalin in Acute Postoperative Painpregabalin and 816 on control treatment. The different surgical
categories were cardiothoracic surgery (1), ENT surgery (3),
laparoscopic cholecystectomy (3), miscellaneous surgery (4),
orthopedic surgery (7), and spine surgery (4). In subgroup
analysis, pregabalin was associated with reduced vomiting only
after miscellaneous procedures (OR and 95% CI, 0.163 [0.073–
0.368], z score 4.375, P< 0.0001), but pregabalin was found
to be associated with reduced postsurgical vomiting in overall
analysis (OR and 95%CI, 0.468 [0.328–0.668], z score4.173,
P< 0.0001).
Postsurgical Nausea and Vomiting
A total of 20 studies provided data on postsurgical nausea
and vomiting (PONV) incidence after pregabalin adminis-
tration,12,14,27,31,32,34,35,38,40,42,43,45,62,66,69,73,79,80,82 with 638
patients treated with pregabalin and 644 on control treatment.
The different surgical categories were ENT surgery (2), gyne-
cologic surgery (8), laparoscopic cholecystectomy (2), miscel-
laneous surgery (6), and spine surgery (2). In subgroup analysis,
pregabalin was associated with reduced PONV inmiscellaneous
surgery only (OR and 95% CI, 0.528 [0.309–0.902], z score
2.339, P< 0.019) but pregabalin was found to be associated
with reduced PONV in overall analysis (OR and 95% CI, 0.592
[0.415–0.845], z score 2.887, P< 0.004).
No evidence of publication bias was seen using funnel plot
analysis with regard to 2- and 24-hour pain scores and 24-hour
morphine-equivalent consumption (Supplementary Figures 2A
to C, http://links.lww.com/MD/A495), or with regard to adverse
effects (Supplementary Figures 2D to h, http://links.lww.com/
MD/A495).
DISCUSSION
This present meta-analysis shows that perioperative
FIGURE 4. Forest plot for primary outcomes of studies under theadministration of pregabalin significantly reduced VAS pain
scores at 2 hours postsurgery in all surgical categories, and at 24
hours postsurgery in all surgical categories with the exception of
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.cardiothoracic and spine procedures. Total morphine consump-
tion at 24 hours postsurgery was significantly reduced in all
surgical categories with the exception of cardiothoracic and
ENT procedures. Adverse effects include significant sedation
after pregabalin in cardiothoracic, orthopedic, spine, and mis-
cellaneous procedures. PONV was significantly reduced after
pregabalin in all, except miscellaneous procedures. Taken
together, results of this meta-analysis show that pregabalin is
useful in reducing postsurgical pain as well as reducing mor-
phine consumption, with concomitant reduction in PONV.
It has long been recognized that different surgical pro-
cedures require procedure-specific pain management.89–92 It is
evident that the degree of pain experienced by patients after
different surgical procedures is not universal, and even some
laparoscopic approaches might result in unexpectedly high
levels of postsurgical pain.93,94 Moreover, the analgesic effi-
cacy of different pain medications might also be different in
different types of surgery. The analgesic efficacy of paraceta-
mol is 2-fold less in orthopedic compared with dental pro-
cedures.95 It has also been found that the analgesic efficacy
between nonsteroidal anti-inflammatory agents and paraceta-
mol depends on the magnitude of the surgical procedure.96 In
addition to differing analgesic effects of the same drug under
different conditions, a 50% decrease in pain might have a
different clinical relevance depending if it were a reduction
from 4 to 2, or 8 to 4 on the VAS pain scale.97 Therefore,
specific recommendations for surgical procedures including
abdominal hysterectomy, laparoscopic cholecystectomy, and
total knee arthroplasty have been made.98 It is in recognition
that pain management should be procedure-specific that pro-
vided the insight to take this approach of subgroup analysis for
this current investigation.
A previous meta-analysis of 11 RCTs10 concluded that
presurgical pregabalin administration did reduce 2-hour pain
diothoracic surgery category.scores and postsurgical opioid requirement. The authors divided
the studies under investigation by pregabalin dose, <300 or
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Medicine  Volume 94, Number 46, November 2015 Meta-Analysis: Pregabalin in Acute Postoperative Painconsumption more than the lower dose. Pregabalin also
reduced opioid-related adverse effects such as vomiting,
but the risk of visual disturbance was greater. Another
recently conducted meta-analysis on 55 RCTs5 concluded
that when all doses and administration regimens were com-
bined, pregabalin was associated with a significant reduction
in pain scores at rest and during movement and opioid
consumption at 24 hours compared with placebo. Pregabalin
was also associated with less postsurgical nausea, vomiting,
and pruritus, although it was associated with higher incidence
of sedation, dizziness, and visual disturbance. These previous
meta-analyses have been criticized for not having investigated
surgical specific-opioid consumption as different procedures
will result in different opioid requirements.99 Hence, this
caveat has been addressed in the present meta-analysis. This
meta-analysis is the first study to investigate the efficacy of
pregabalin when used under different surgical procedures in
acknowledgment that different surgical procedures result in
variable pain intensity and different opioid requirements,94
and that the efficacy of perioperative analgesia varies accord-
ing to surgical type.98 By identifying the types of surgery that
would benefit from pregabalin, clinicians can improve effi-
ciency in treating acute postsurgical pain and can better
allocate resources.
This present meta-analysis is the first to show that the
analgesic effect of perioperative pregabalin is procedure
specific. With regard to the cardiothoracic procedure category,
pain at 2 hours postsurgery was significantly lower in the
pregabalin group, but no difference was seen at 24 hours
postsurgery. It should be noted that only 2 studies showed data
for 24-hour VAS pain scores, therefore there are insufficient
data to draw definitive conclusions, and the only study showing
reduction in morphine consumption after pregabalin did not
FIGURE 5. Forest plot for primary outcomes of studies under theshow either 2-, or 24-hour VAS pain scores. No data on PONV
were given and significant sedation was seen after pregabalin,
so although overall, pregabalin appears to be efficacious for
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.acute postsurgical pain in cardiothoracic procedures, caution
should be exercised when deciding to use pregabalin.
In the ENT category, although both 2- and 24-hour post-
surgical pain was shown to be reduced in the pregabalin group,
there was no difference in total morphine-equivalent consump-
tion at 24 hours between pregabalin and the control group.
PONV is more common in patients undergoing ENT, compared
with other procedures,100 and as no difference was seen in either
sedation or PONV, pregabalin can be recommended for use in
ENT procedures.
There is strong evidence to recommend the use of prega-
balin in gynecologic procedures, due to the large effects sizes
with regard to pain reduction, and no evidence of increased
sedation and PONV.
With regard to laparoscopic cholecystectomy, caution
should be exercised when considering pregabalin, as although
pain scores at 2 and 24 hours, and morphine-equivalent con-
sumption are reduced, the OR seen for sedation was extremely
high, even though, due to the heterogeneity of the studies, this
was not statistically significant. Pain scores tend to be low after
laparoscopic cholecystectomy procedures (not >5 on the VAS
at 2 hours postsurgery according to the studies included here),
and as pain reduction at 24 hours postsurgery and total mor-
phine-equivalent consumption is modest in terms of effect-size,
the risk–benefit ratio should be carefully considered.
Although pain scores at 2 and 24 hours, and morphine-
equivalent consumption are reduced in orthopedic surgery, the
reduction of pain scores at 2 hours is modest and sedation was
significantly increased in the pregabalin group. The increased
risk of sedation might be preferable when weighed with the
significantly decreased morphine-equivalent consumed. Con-
sidering that many orthopedic procedures are performed in the
elderly101 the risk of sedation might outweigh the benefit of
r, nose and throat surgery category.modest decrease in pain scores.
With regard to spinal, and also miscellaneous surgeries, a
large decrease in pain at 2 hours and total morphine
www.md-journal.com | 19
FIGURE 6. A,B Forest plot for primary outcomes of studies under the gynecologic surgery category.
Lam et al Medicine  Volume 94, Number 46, November 2015
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at 24 hours postsurgery. Considering the high incidence of
sedation, in both spinal and miscellaneous surgical procedures,
FIGURE 7. Forest plot for primary outcomes of studies under thepregabalin should be used with caution.
It should be noted that although statistically significant
reductions in the pain scores were noted in all surgical
FIGURE 8. Forest plot for primary outcomes of studies under the ort
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.procedures in this meta-analysis, the magnitude of effect is
relatively small. For example, in Bafna et al,26 Balaban et al,44
Aydogan et al,72 Eskandar and Ebeid,51 and Lee et al,55 stat-
aroscopic cholecystectomy category.istically significant decreases in pain scores at 2 hours post-
surgery were reported, although the standard difference in mean




Lam et al Medicine  Volume 94, Number 46, November 2015<1 point on the VAS pain score. Studies on clinically signifi-
cant decreases in VAS/NRS pain scores have demonstrated that
an average decrease in pain score of at least 1.80 points on NRS
scores or 1.3 to 2.8 points on VAS pain scores are required for
the decrease to be considered clinically meaningful.102,103 The
reduction in pain scores demonstrated in the studies included in
this meta-analysis may reach statistical significance, but might
be too small to be considered of clinical significance.
An interesting finding from study by Mishriky et al5 was
that a single preoperative dose was as effective as multiple
doses, and that smaller doses (75mg) were as effective as
FIGURE 9. Forest plot for primary outcomes of studies under thelarger (300mg) doses in terms of reducing opioid consumption.
It was beyond the scope of this present meta-analysis to sub-
divide the studies according to surgical-type as well as dosages
FIGURE 10. Forest plot for primary outcomes of studies under the m
22 | www.md-journal.comand dosing regimens, although an analysis of single versus
multiple doses did not reveal any differences in efficacy regard-
ing 2-hour postsurgical pain. Subgroup analyses performed in
this present meta-analysis according to whether single or
multiple doses of pregabalin were used showed a statistically
significant reduction in 24-hour postsurgical pain for both
single and multiple dose, contrary to previous studies.10 In
particular, with regard to the gynecologic category, it was
noted, that 8 out of 13 studies showed significant reduction
in 24-hour postsurgical pain score, of which, 6 studies used a
single-dose of pregabalin and 2 used multiple dose. The dose of
ne surgery category.pregabalin used included low dose (75mg), intermediate dose
(100–150mg), and high dose (>150mg). Sensitivity analysis
data from this present meta-analysis do not show that higher
iscellaneous surgery category.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
3. Hindmarch I, Trick L, Ridout F. A double-blind, placebo- anddoses were more effective at reducing pain scores when com-
pared with lower doses (data not shown). There is no evidence
from this current meta-analysis to recommend multiple dosing,
or dosages >75mg, in any of the surgical procedures that has
investigated dosing.
Well established adverse effects of pregabalin are sedation,
dizziness, and headache, and so pregabalin should be used with
caution in an ambulatory setting.104 As shown in previous meta-
analyses, pregabalin is associated with increased incidence of
visual disturbances and sedation; but reduced incidence of
PONV.5,10 Of the 15 studies included in this analysis that
showed such an association, only 4 provided information on
morphine-equivalent consumption. Two of these 4 studies
showed a pregabalin-associated reduction in morphine-equiv-
alent consumption, whereas the remaining 2 showed no
reduction. Due to the limited data available, it is not possible
to ascertain whether the reduction in incidence of PONV is due
to a direct effect of pregabalin or a result of reduced opioid
consumption. Opioids are considered the primary analgesic
therapy in postsurgical pain, but are associated with many
dose-related adverse effects such as sedation, respiratory
depression, postsurgical nausea and vomiting, urinary retention,
ileus, and constipation.105 This meta-analysis shows that admin-
istration of pregabalin reduced morphine-equivalent consump-
tion in most surgical categories, and looking at the effect size
data show that there is up to 30% reduction. These data indicate
pregabalin is useful to reduce opioid induced adverse effects, as
seen by the reduced incidence of nausea and vomiting.
Meta-analyses have been conducted to assess the effects of
perioperative gabapentin on postoperative pain,106–108 and
although all the studies concluded that perioperative gabapentin
was able to reduce postsurgical pain and 24-hour morphine
consumption, a recent meta-regression on RCTs of periopera-
tive gabapentin that included 133 trials, found that these effects
of gabapentin might have been overestimated by statistically
significant small study effects.109 Small study effects may also
explain the difference in findings between our current meta-
analysis and previously published work on pregabalin.
A problem inherent with meta-analyses using the random-
effects model is the assumption that the effects underlying
different studies are drawn from a normal distribution.110 This
is seldom true, especially in the case of pain scores, which
commonly show a skewed distribution. Much data used in this
present meta-analysis were drawn from median, rather than the
mean values required. Efforts were made to reduce the impact of
clinical heterogeneity by analyzing data according to the type of
surgery. Some studies are heterogeneous in themselves in that
the investigators had included different surgical types in their
own analysis.84 Methodologic heterogeneity also exists in the
assessment of pain and sedation. In addition to the commonly
used VAS pain scores and NRS pain scores, which have been
shown to correlate well,7 Roger Pain Scale was used in 1
study.76 Similarly, with regard to assessing sedation, both the
Ramsay Sedation Scale and Richmond Agitation Sedation Scale
were used. Although these scales have been shown to correlate
well,111 some studies have neither stated with which method
they have assessed sedation, nor at which time postsurgery, was
the assessment carried out. Some studies have instead reported
on either presence or absence of somnolence and these data
were excluded in the analysis for sedation effects. It is noted
here although that none of the studies included in this present
Medicine  Volume 94, Number 46, November 2015meta-analysis were powered to assess pregabalin-associated
adverse effects, as these were secondary outcomes of the
studies.
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.In the setting of an ideal RCT, subjects are placed in a
closely monitored environment, where their pain intensity is
regularly assessed. Analgesia is provided on demand by the
nursing staff in the form of nursing-controlled analgesia or
delivered by the subjects themselves using patient-controlled
analgesia (PCA). The pain intensity of both control and treat-
ment group should therefore be titrated to similar levels,
although total opioid consumption and time to first analgesic
would differ between the 2 groups based on the effectiveness of
the treatment. Limitations certainly exist for both nursing-
controlled analgesia and PCA in providing adequate analgesia.
For the former, inadequacy of nursing staff can result in delay in
delivering analgesics; for the latter, malfunctioning, poor initial
titration, or incorrect setup of the PCA instruments can also
prevent timely delivery of analgesics. Such limitations, how-
ever, would apply to both control and treatment group in a well-
conducted trial and the pain scores of both control and treatment
group will therefore be similar. It is proposed here that pain
scores should only be 1 of the primary outcomes in such
trials, whereas the more pertinent parameters would be
changes in analgesic consumption and in time to first analgesic
requirement.
Pain is not only affected by gender, age, and psychologic
well-being, but also by polygenetic elements. The current list
of genetic polymorphisms that may affect the action of
analgesics is growing rapidly, but 1 of the enzyme systems
of high relevance to opioids is the cytochrome P450 system.112
As it has been shown that polymorphisms that affect opioid
metabolism are found in up to 30% of the general popu-
lation,112 future clinical trials utilizing opioid consumption
as an outcome could take genetic variability into consider-
ation. The fact that none of the studies included here have
factored in the genetic variability in opioid metabolism brings
in another layer of heterogeneity, especially when an increase
in opioid requirement in 1 or 2 patients can have substantial
impact in the overall results.
Out of the 74 studies assessed in this meta-analysis, only
12 investigated the effects of pregabalin on chronic (3
months) postsurgical pain.19,21,29,30,33,41,61,63,65,76,79 Chronic
postsurgical pain is an underexplored area and more studies
are required to assess the efficacy of pregabalin in this regard.
CONCLUSIONS
In conclusion, the analgesic efficacy and adverse effects of
pregabalin might not be similar under all surgical categories.
Although sedation may be increased, especially in cardiothor-
acic, spinal, and miscellaneous procedures, this was not seen in
ENT, gynecologic, or laparoscopic cholecystectomy pro-
cedures. Two-hour VAS scores were reduced in all procedures,
but effect sizes varied greatly. Taken together, this meta-
analysis shows strong evidence that consideration for the use
of pregabalin in postsurgical pain should be procedure-specific.
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